Novel inhibitors of RANKL-induced osteoclastogenesis: Design, synthesis, and biological evaluation of 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-diones-Reference-Cited by-同舟云学术

Novel inhibitors of RANKL-induced osteoclastogenesis: Design, synthesis, and biological evaluation of 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-diones

Published:2015-08 Issue:15 Volume:23 Page:4522-4532
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Lee Chia-Chung,Liu Fei-Lan,Chen Chun-Liang,Chen Tsung-Chih,Liu Feng-Cheng,Ahmed Ali Ahmed Atef,Chang Deh-Ming,Huang Hsu-Shan

Funder

National Science Council

Ministry of Science and Technology

Taipei Medical University

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference60 articles.

1. Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption

2. Bone remodelling at a glance

3. Osteoclast-derived activity in the coupling of bone formation to resorption

4. Molecular control of bone remodeling and osteoporosis

5. Pathogenesis of bone fragility in women and men

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asymmetric Cross Couplings of Trifluoromethyl Radical to Vinylarenes with N‐Hydroxy‐oxazinediones and Subsequent Aerobic Oxidative Homocoupling of 2‐Naphthols Catalysed by Chiral Vanadyl Complexes;Advanced Synthesis & Catalysis;2023-12-06

2. Multi-Omics Identification of Genetic Alterations in Head and Neck Squamous Cell Carcinoma and Therapeutic Efficacy of HNC018 as a Novel Multi-Target Agent for c-MET/STAT3/AKT Signaling Axis;International Journal of Molecular Sciences;2023-06-16

3. In silico study of novel niclosamide derivatives, SARS-CoV-2 nonstructural proteins catalytic residue-targeting small molecules drug candidates;Arabian Journal of Chemistry;2023-05

4. Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures;Cells;2023-01-09

5. Leveraging Bulk and Single-Cell RNA Sequencing Data of NSCLC Tumor Microenvironment and Therapeutic Potential of NLOC-15A, A Novel Multi-Target Small Molecule;Frontiers in Immunology;2022-05-17